Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-000893
Filing Date
2025-02-07
Accepted
2025-02-07 17:36:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9648
2 d11598789_ex99-a.htm EX-99 4517
3 d11598789_ex99-b.htm EX-99 694
  Complete submission text file 0000919574-25-000893.txt   16544
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Subject) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93650 | Film No.: 25603021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)